Md. Code Ann., Ins. § 15-1611
Actions prohibited by pharmacy benefits manager
Effective Jan 1, 2022Added by Acts 2018, c. 217, § 1, eff. Oct. 1, 2018; Acts 2018, c. 218, § 1, eff. Oct. 1, 2018. Amended by Acts 2021, c. 109, § 5; Acts 2021, c. 358, § 1, eff. Jan. 1, 2022.State of Maryland
- (a) This section applies only to a pharmacy benefits manager that provides pharmacy benefits management services on behalf of a carrier.
(b) A pharmacy benefits manager may not prohibit a pharmacy or pharmacist from:
- (1) providing a beneficiary with information regarding the retail price for a prescription drug or the amount of the cost share for which the beneficiary is responsible for a prescription drug;
- (2) discussing with a beneficiary information regarding the retail price for a prescription drug or the amount of the cost share for which the beneficiary is responsible for a prescription drug; or
- (3) if a more affordable drug is available than one on the purchaser's formulary and the requirements for a therapeutic interchange under §§ 15-1633.1 through 15-1639 of this subtitle are met, selling the more affordable alternative to the beneficiary.
- (c) This section may not be construed to alter the requirements for a therapeutic interchange under §§ 15-1633.1 through 15-1639 of this subtitle.
Added by Acts 2018, c. 217, § 1, eff. Oct. 1, 2018; Acts 2018, c. 218, § 1, eff. Oct. 1, 2018. Amended by Acts 2021, c. 109, § 5; Acts 2021, c. 358, § 1, eff. Jan. 1, 2022.